| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Total Income - EUR | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 4.063 | 70 | 91 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -4.063 | -70 | -91 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -4.063 | -70 | -91 | - | - | - | - | - | - | - |
| Employees | 0 | 0 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Ipromed S.a.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 127.063 | 125.697 | 123.501 | - | - | - | - | - | - | - |
| Current Assets | 7.037 | 6.966 | 6.826 | - | - | - | - | - | - | - |
| Inventories | 12 | 12 | 12 | - | - | - | - | - | - | - |
| Receivables | 6.944 | 6.874 | 6.757 | - | - | - | - | - | - | - |
| Cash | 81 | 80 | 57 | - | - | - | - | - | - | - |
| Shareholders Funds | 62.447 | 61.740 | 60.604 | - | - | - | - | - | - | - |
| Social Capital | 146.232 | 144.740 | 142.291 | - | - | - | - | - | - | - |
| Debts | 71.654 | 70.923 | 69.723 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Ipromed S.a.